Frontier Group Holdings, Inc. (ULCC)
Cerebras Systems Long-Term View: Delivery Speed Is The Next Frontier Of AI
Cerebras Systems Inc. leads AI inference hardware with its WSEs, offering unmatched token generation speed and a strong first-mover advantage. CBRS's WSE-3 delivers 7,000x the bandwidth of Nvidia's H100, enabling rapid decode and supporting major contracts with OpenAI, Amazon, and AMD. Management is prioritizing cloud segment expansion, guiding flat Q2 revenue at $194M and gross margins of 36-38%, with a robust $2.2B cash position.
Are You Looking for a Top Momentum Pick? Why Frontier Group Holdings (ULCC) is a Great Choice
Does Frontier Group Holdings (ULCC) have what it takes to be a top stock pick for momentum investors? Let's find out.
Fast-paced Momentum Stock Frontier Group (ULCC) Is Still Trading at a Bargain
Frontier Group (ULCC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Nvidia's Latest Frontier AI Bet Might Be Its Most Exciting Yet
Nvidia (NASDAQ:NVDA | NVDA Price Prediction) just keeps making smart, though “circular” deals in AI.
Frontier Group Q2 Earnings Call Highlights
Frontier Group NASDAQ: ULCC reported second-quarter results that exceeded its prior outlook, driven by stronger revenue, more disciplined revenue management and an improved competitive capacity environment.
Frontier Group (ULCC) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Frontier Group (ULCC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Frontier Group Holdings (ULCC) Reports Q2 Loss, Beats Revenue Estimates
Frontier Group Holdings (ULCC) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to a loss of $0.31 per share a year ago.
Eledon: At The Center Of The Next Medical Frontier
Eledon Pharmaceuticals (ELDN) is rated Buy, with tegoprubart showing strong promise post-Phase 2 in kidney transplantation and significant undervaluation versus risk-adjusted fair value. Tegoprubart targets kidney transplants, Type 1 Diabetes islet cell transplants, and ALS, with potential multi-billion dollar annual revenue if approved and established. Despite reliance on a single asset, ELDN's risk-adjusted fair value is $11.69 per share, over triple the current price, even after conservative success probabilities.
Frontier IP Group: Cambridge Raman Imaging secures €400,000 European grant
Frontier IP Group PLC (LSE:FIPP, FRA:8WT) said its portfolio company Cambridge Raman Imaging has secured a €400,000 European grant as it targets pharmaceutical manufacturing quality control and prepares pilot testing with two industry groups. The non-dilutive European Innovation Council funding will support the scale-up of CRI's high-speed Raman imaging and artificial intelligence technology.
Frontier Airlines to add Starlink high-speed Wi-Fi on flights
Frontier Airlines will begin rolling out SpaceX's Starlink inflight internet in 2027, offering high-speed Wi-Fi while investing in new amenities to attract more travelers.
Frontier Airlines to debut in-flight Wi-Fi in 2027 with SpaceX's Starlink
Frontier Airlines said it will debut Starlink satellite internet early next year. The carrier doesn't currently offer in-flight Wi-Fi.
Frontier Airlines, a Wi-Fi Holdout, Is Partnering With SpaceX's Starlink
The budget airline has been rolling out more amenities to target customers willing to pay for premium travel.
